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Summary
Transcription by RNA polymerase II (RNAPII) is a cen-
tral process in eukaryotic gene regulation. While
atomic details exist for the yeast RNAPII, characteriza-
tion of the human complex lags behind, mostly due to
the inability to obtain large quantities of purified mate-
rial. Although the complexes have the same protein
composition and high sequence similarity, under-
standing of transcription and of transcription-coupled
DNA repair (TCR) in humans will require the use of
human proteins in structural studies. We have used
cryo-electron microscopy, image reconstruction, and
variance analysis to characterize the structure and dy-
namics of human RNAPII (hRNAPII). Our studies show
that hRNAPII in solution parallels the conformational
flexibility of the yeast structures crystallized in differ-
ent states but also illustrate a more extensive confor-
mational range with potential biological significance.
This hRNAPII study will serve as a structural platform
to build up higher-order transcription and TCR com-
plexes and to gain information that may be unique to
the human RNAPII system.
Introduction
RNAP II is a large protein complex of 12 subunits and
over half a million Daltons molecular weight, central to
the process of gene regulation in all eukaryotes. Gene
transcription involves a number of additional protein
complexes, including general transcription factors re-
quired for promoter targeting and melting, loading of
RNAPII onto the DNA, and phosphorylation of the RNA-
PII C-terminal domain (CTD) (Orphanides et al., 1996;
Roeder, 1996). Furthermore, regulation of RNAPII activ-
ity requires the action of sequence-specific activators or
repressors that bind to cognate DNA elements (Mirko-
vitch et al., 1987), as well as coactivators (e.g., mediator)
and chromatin-remodeling and -modifying complexes
(Malik and Roeder, 2000; Jenuwein and Allis, 2001; Nar-
likar et al., 2002). Some of these factors interact directly
with RNAPII and have the potential to affect its confor-
mation and activity. RNAPII also plays a central role in
the process of transcription-coupled DNA repair (TCR),
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transcription-blocking DNA lesions from transcribed
strands of active genes (Mellon et al., 1987) and that is
essential for normal postnatal growth and development
in humans, resulting in the profound genetic disorder
Cockayne syndrome when defective (Lehmann, 2003).
Although detection of the stalled polymerase is the initial
step in this pathway (Svejstrup, 2002; Ljungman and
Lane, 2004), it is not yet understood in molecular detail
how the stalled RNAPII is recognized, nor what changes
it undergoes during the process of lesion resolution
(Svejstrup, 2003). It has recently been proposed that
the human TCR machinery may open the clamp that
maintains processivity of RNAPII to allow access of re-
pair proteins to the DNA lesion (Sarker et al., 2005).
Over the last 6 years, the atomic details of the yeast
Saccharomyces cerevisiae RNAPII complex have be-
come available, producing a richness of structural and
functional information about this enzyme and the pro-
cess of eukaryotic transcription (Cramer et al., 2000,
2001; Gnatt et al., 2001; Armache et al., 2003). In the
present study, we have used cryo-electron microscopy
and single-particle image analysis to characterize, at in-
termediate resolution, the structure of human RNAPII.
We show that, as expected by sequence conservation,
the overall structure of human RNAPII is similar to the
yeast crystal structure. There are, however, a number
of notable differences. These include additional mass
in our reconstruction of the human complex that corre-
spond to disordered regions in the yeast crystal struc-
tures, or sites of actual difference in sequence length be-
tween the two enzymes. Furthermore, using novel 3D
statistical-analysis methods, we can clearly detect the
presence of different conformational states in the hu-
man complex. These conformations, which coexist in
solution, include the movement of the clamp head de-
scribed by different yeast crystal structures, but appear
more extensive, likely due to both the solution state of
the sample and to differences between the human and
yeast complexes. We discuss the potential significance
of this conformational flexibility of human RNAPII for its
biological functions.
Results
3D Cryo-EM Reconstruction of Human RNAPII
Although RNAPII is highly conserved in eukaryotes,
there are significant differences between the higher-or-
der and lower-order eukaryotic complex (Cramer et al.,
2001; Chen et al., 2004). To identify structural features
in RNAPII that could be unique to higher-order eukary-
otes, we analyzed the human RNAPII complex by cryo-
electron microscopy (EM). Human RNAPII (hRNAPII) pu-
rified from HeLa cell nuclei (Figure S1A available with
this article online) and active in in vitro transcriptional as-
says (Figure S1B) was visualized by cryo-negative stain-
ing with ammonium molybdate (Adrian et al., 1998)
(Figure 1A). To estimate the overall shape, distribution
of views, and potential image processing strategy for
3D image reconstruction, boxed particles were
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hierarchical ascendant classification (HAC) using
IMAGIC (van Heel et al., 1996) to generate reference-
free class averages with improved signal-to-noise ratio
(Figure 1B). Comparison of these hRNAPII class aver-
ages with projections from the filtered crystallographic
structure of the complete yeast RNAPII (yRNAPII) (PDB
entry 1NT9) (Armache et al., 2003) (see Figures 1C and
1D) confirmed the expected similarity of these struc-
tures and led us to use yRNAPII as an initial reference
for Euler angle assignment. We low-pass filtered the
yRNAPII structure to 50 A˚ to prevent bias from the yeast
structure at higher resolution. This low-resolution yeast
model was only used for the first angular assignment
cycle, all the subsequent 3D refinement cycles used ref-
erences reconstructed from the newly aligned hRNAPII
cryo-EM images. After several cycles of projection
matching and 3D reconstruction using SPIDER (Penc-
zek et al., 1994), the final refinement and CTF correction
were performed with FREALIGN (Grigorieff, 1998). The
resolution of the final reconstruction, which included
about 6200 particles, is 22 A˚ according to the 0.143
cut-off level in the Fourier shell correlation curve (Rosen-
thal and Henderson, 2003) (Figure S2A) with the data set
covering the full range of Euler angles (Figure S2B).
Figure 1. Two-Dimensional Electron Microscopy Analysis of
hRNAPII and Comparison with yRNAPII
(A) Raw image of cryo-negatively stained hRNAPII (scale bar =
200 A˚).
(B) Class averages of hRNAPII corresponding to different views of
the complex.
(C) Corresponding reprojections of the yRNAPII crystal structure
after filtering to 50 A˚.
(D) Corresponding views of the filtered yRNAPII structure. This fil-
tered density was used as initial reference for projection matching
of the cryo-EM data set.As for the yeast enzyme, hRNAPII has a globular
shape with dimensions of 160 A˚ by 120 A˚ by 110 A˚, split
by a large central cleft and displaying a very clear protru-
sion (Figure 2A). The most prominent features in the
yeast crystal structure are easily identifiable, such as
the clamp, the Rbp1, Rbp9, and Rbp5 jaws, the Rpb4/
7 stalk, the wall, or the foot. In order to better compare
the yeast and human complexes, the yeast atomic
model was docked into our EM density map of hRNAPII.
An initial position was obtained manually and then re-
fined with the SITUS program colores (Wriggers and Bir-
manns, 2001; Chacon and Wriggers, 2002). Of all the
available atomic structures, the 12 subunit yeast com-
plex (PDB entry 1Y1V) (Kettenberger et al., 2004) and
the elongation complex (PDB entries 1Y1W and 1Y77)
(Kettenberger et al., 2004), both characterized by a
closed clamp conformation, gave the closest fit (with
the three fittings being indistinguishable at the resolu-
tion of our reconstruction). This indicates that the human
complex that includes Rbp4/7 adopts in solution (on av-
erage; see later) a structure that resembles more closely
that of a yeast elongation complex. This is so even in the
absence of DNA, as has also been seen for the full-yeast
enzyme (including the Rbp4/7 stalk) (Armache et al.,
2003; Bushnell and Kornberg, 2003). Overall, the fit at
this resolution is good, although some clear discrep-
ancies are detectable. Significant differences are
a markedly bulkier clamp and Rpb5 jaw of the hRNAPII,
which also displays additional density between the wall
and clamp (Figures 2A and 2B).
In order to assign the differences between the human
EM density map and the docked yeast crystal structure,
the discrepancies in sequence length between the yeast
and human enzymes were mapped onto the docked
model from yeast (PDB entry 1Y1V) (Figure 2B) (see de-
tails in Experimental Procedures and Table S1). We also
took into account the residues that were not included in
the yeast model due to disorder. The largest deletions in
hRNAPII are localized in Rpb4, constituting part of the
stalk. The largest missing region (66 amino acids) is sit-
uated at the back of the stalk (relative to the DNA-bind-
ing cleft), which agrees with the smaller size of the hu-
man stalk. Two other deletions (in Rpb4 and the C
terminus of Rpb2) are localized at the interface between
the clamp core and the stalk, where the latter forms
a wedge into the core complex (yellow highlights in Ta-
ble S1). These deletions may be the reason why the
human stalk adopts a slightly different position in our
EM density map and why it may be slightly more mobile
than its yeast counterpart (see following section and
Discussion). Some large flexible domains, such as ‘‘ex-
ternal 1,’’ and the C terminus of Rpb9, protruding from
the EM map at the bottom of the complex (opposite
from the stalk), are also substantially shorter in humans.
Some additional density is visible in the human 3D map
protruding on top of the site of the CTD linker and filling
the gap between the C terminus of Rpb3 (not localized in
the crystal structure) and Rpb1 (not shown). There is
some extra density at the site of the N terminus of
Rpb6, where 70 amino acids are missing in the crystal
structure (44 in human). Other differences cannot be
so easily explained in terms of missing or extra se-
quences but are likely due to the flexible character of
some of the domains. For example, some loops at the
Architecture and Flexibility of Human RNAP II
1693Figure 2. Cryo-EM Structure of hRNAPII
(A) Final, CTF-corrected reconstruction of hRNAPII at 22 A˚ resolution in two orthogonal views. The most prominent features are indicated.
(B) Rigid-body docking of the yeast 12 subunit complex (PDB entry 1Y1V) (Kettenberger et al., 2004) into the 3D EM density map (mesh). Dele-
tions in the sequence of hRNAPII are colored in green. Insertions in hRNAPII and residues absent from the yeast crystal structures (flexible) are
represented as red dotted lines.tip of the clamp head and of the Rpb2 protrusion extend-
ing outside of the EM density are known to be flexible in
the yeast crystal structures. Similarly, the RNA exit
channel between the wall domain and the clamp ap-
pears full, but this may be due to contributions from
the flexible wall ‘‘flap loop’’ and/or the nearby, disor-
dered CTD, both of them completely absent in all crystal
structures. The Rpb1/Rpb9 jaw protrudes out of the EM
density map in a region that is also poorly defined in the
yeast crystal structures. Additionally, other size and
shape differences, such as the bulkier Rpb5 jaw, the
thinner stalk tip, or the difference shape of the clamp
head, are not readily explainable based on sequence
but originate from flexibility in the hRNAPII in solutionas well as conformational differences with the crystal
yRNAPII structures (see below).
We have additionally generated a homology model of
the full human complex based on the yeast 12 subunit
complex structure (1Y1V) that is presented in the Sup-
plemental Data. Both structures are very similar, as ex-
pected from their sequence homology; only the stalk is
different, smaller due to the shorter Rpb4 peptide and
adopting a slightly different position, more tilted toward
the direction of the jaws when looking at the enzyme
central cleft (compare left side of Figure 2 and
Figure S5). An independent rigid body docking of the ho-
mology model was obtained with SITUS. The position of
the core enzyme is indistinguishable from that of the
Structure
1694Figure 3. Detection of Conformational Flexi-
bility in hRNAPII
Reclassification of classes corresponding to
two different particle views ([A and B], top
row) into two different conformations (1 and
2, bottom row). Conformation 2 of the view
shown on the left shows a clear movement
of the jaw and clamp regions indicated with
arrows. A corresponding change for a qua-
siorthogonal view on the right is also indi-
cated with an arrow.yRNAPII docking; only the stalk position is different.
Even though its smaller size is more in agreement with
the EM density map, the angle relative to the core
causes it to protrude slightly out of the EM envelope.
Thus, it is likely that the homology model is not accurate
concerning the relative position of the stalk with respect
to the core, not surprisingly, given the significant differ-
ences in sequence in this region of contact. The conclu-
sions that can be drawn from the human homology
model are basically the same we have drawn by using
the yeast structures: differences between the solution
structure of hRNAPII and the yeast crytal structures
are due to (1) small sections, like part of the stalk, that
are smaller in the human complex; (2) extra densities
due to human insertions or to disordered loop regions
not present in the crystal structures, but contributing
to the low-resolution EM map; and (3) possible confor-
mational differences in mobile regions.
Detection and Characterization of Conformational
Flexibility in Human RNAPII
The structural analysis of RNA polymerase molecules,
whether single subunits like the T7 RNA polymerase or
multisubunit complexes like the eukaryotic RNAPI and
RNAPII, has shown them to behave in a highly dynamic
manner (Cheetham et al., 1999; Cramer et al., 2001;
Gnatt et al., 2001; Craighead et al., 2002; Tahirov et al.,
2002; De Carlo et al., 2003). These conformational
changes have been associated with the RNA polymer-
ase clamping onto the DNA (during transcriptional initia-
tion of RNAPII [Gnatt et al., 2001] or during the transition
to elongation in T7 RNA polymerase [Cheetham et al.,
1999; Tahirov et al., 2002]). The relatively low resolution
of our reconstruction, in spite of the large number of par-
ticles analyzed, would be consistent with conforma-
tional heterogeneity in our solution sample, as mixing
of conformations would result in poor alignment and
smearing out of the higher-resolution features. To iden-
tify hRNAPII complexes corresponding to distinctive
conformations, we carried out further 2D analysis of par-
ticles assigned to a particular view of the hRNAPII. The
assumption is that the overall shape of a particular
view dominates its assignment to a given projection dur-
ing projection matching, and that subsequent subclassi-
fication within a given angular group would distinguish
potential conformational differences between particles.Conformational flexibility is clearly illustrated in our 2D
reclassification of particles assigned to certain Euler an-
gles (Figure 3). Particles assigned to the views depicted
at the top of Figures 3A and 3B partition between two
clearly distinct conformations (shown at the bottom).
The conformations exhibit a significant relative move-
ment of the clamp and possibly the jaws, moving from
a straighter (Figure 3A1) to a more curved conformation
(Figure 3A2). Reclassification in the view shown in
Figure 3B also seems to depict a movement of the clamp
region. Analysis of other views was less clear, likely be-
cause the trajectory of the mobile elements is closer to
the direction of projection.
In order to further characterize this conformational
variability, we calculated the 3D variance of our full
data set using the bootstrap technique developed by
Penczek (Grob et al., 2006; Penczek et al., 2006a). The
variance values obtained were significantly higher than
the background variance in a number of areas within the
structure. Superposition of the 3D variance with the 3D
reconstruction map (Figure 4A) and the docked yeast
structure (Figure 4B) allowed us to identify the structural
elements corresponding to the most variable regions in
hRNAPII (see Table S1, fourth column, for a subunit-by-
subunit description). The high-variance regions can be
divided into three categories depending on their loca-
tion: cleft, cavities and interfaces, and unstructured or
highly flexible regions. The variance in the DNA-binding
cleft has the highest value. Four regions correspond to
this cleft category: a bilobal area extending between
the clamp head and the Rpb2 lobe (Figures 4B1 and
4C1), an area localized where the DNA/RNA hybrid has
been shown to bind in the yeast crystal structures (Fig-
ures 4B2 and 4C2), the Rpb2 ‘‘anchor’’ between switch3
and switch4 (Figures 4B3 and 4C3), and the thin connec-
tion between the part of the Rpb1 jaw that contacts
Rpb5 and the part that contacts Rpb9 (Figure 4B4).
These high-variance areas overall parallel the conforma-
tional changes we observe through 2D classification
(Figure 3). The second category is localized mostly on
the back of the complex (see Figures S3 and S4), in cav-
ities and possibly interfaces between modules, such as
the pore occupied by the disordered ‘‘trigger loop’’ (Ket-
tenberger et al., 2003) and the interface between the foot
region and the cleft. The third category corresponds to
regions of variance visible outside of the density map
Architecture and Flexibility of Human RNAP II
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(A) Three-dimensional variance map (yellow) superimposed onto the reconstruction of human RNAPII (blue mesh). The DNA and DNA/RNA hy-
brid path, known from the docking with the yeast elongation complex crystal structure (Gnatt et al., 2001; Kettenberger et al., 2004), are sche-
matically shown as dashed lines.
(B) Three-dimensional variance superimposed onto the yeast 12 subunit complex structure (PDB 1Y1V) (Kettenberger et al., 2004). The main do-
mains are represented in different colors and labeled. The different areas of the 3D variance are numbered 1 through 6.
(C1–C3) Details of the 3D variance regions 1 to 3.that are not present due to disorder in the yeast atomic
structure and would therefore correspond to flexible el-
ements extending out of the main complex. These in-
clude the missing N terminus of Rpb6 (Figure 4B5),
which likely contacts Rpb1 and Rpb5, and a series of
satellites extending between the CTD linker and the
dock region of Rpb1 (Figure 4B6), which could corre-
spond to the unstructured CTD, and/or the wall flap
loop. We can also include in this category some variance
visible at the tip of the Rpb1/Rpb9 jaw (Figure 4B4).
Some variance is also visible in the Rpb4/7 stalk.
In order to further characterize the structural flexibility
giving rise to regions of high variance, we carried out tar-
geted classification for some of the high-variance areasfollowed by 3D reconstruction (Grob et al., 2006; Penc-
zek et al., 2006b) (see also Experimental Procedures).
The classification of the data set within a mask gener-
ated from the variance at the tip of the clamp head
gave a clear indication that the Rpb1/Rpb2 clamp and
the Rpb2 lobe adopt different conformations in solution.
The data were partitioned between two main classes,
corresponding to an open and a closed cleft. Three-di-
mensional reconstructions of these two states showed
a simultaneous repositioning of the clamp head and of
the lobe-jaw module (Figure 5), rotating either toward
(conformation 1, Figure 5A) or away from the cleft (con-
formation 2, Figure 5B) and thus making it less or
more accessible to DNA, respectively. Another notable
Structure
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Two conformations of the cleft of hRNAPII resulting from the data reclassification within the high-variance region 1. (A) Closed conformation
(blue); (B) open conformation (gold). Two orthogonal views for each conformation are shown in the top row as isosurfaces. Docking of the yeast
RNAPII crystal structure (PDB 1Y1V) superimposed onto the two conformations is shown for one of the views in the bottom row. Movements
(indicated with arrows) of the clamp and jaw-lobe domains (shown in dark red) relative to the rest of the complex would be necessary to get
an exact fit with the crystallographic data.difference between the two conformations is the appar-
ent density of the stalk, weaker in conformation 1, stron-
ger in 2. Such a difference suggests that conformation 1
contains a mixture of stalk orientations, while conforma-
tion 2 has selected for a more defined position of the
stalk. This interpretation is consistent with the position
of the clamp in the open conformation 2, which makes
additional contacts with the stalk and potentially stabi-
lizes its base. Alternatively, conformation 2 may be en-
riched in Rpb4/7. These two proteins are known to be
present in substoichiometric quantities in yeast (Bush-
nell and Kornberg, 2003; Armache et al., 2005), but no
similar phenomenon has yet been reported for mamma-
lian RNAPII. Finally, the lower jaw module contacting the
Rpb2 lobe appears better defined in conformation 2
than in conformation 1 or in the initial reconstruction
from the entire data set. Attempts to dock a yeast crystal
structure into the two new densities showed that it wasnot possible to obtain an optimal fit for the lobe-jaw and
the clamp regions simultaneously when using rigid-
body fitting. The best docking was obtained with the
crystal structure of the TFIIB-core enzyme complex
(missing the Rpb4/7 stalk) (Bushnell et al., 2004) fitted
into conformation 1. A better fit is achieved if the two
modules are rotated independently about axes pointing
toward the viewer in Figure 5 (bottom half), perpendicu-
lar to both the downstream DNA running along the cleft
and the DNA/RNA hybrid directions. This analysis leads
to the conclusion that the two conformations isolated
from the human complex in solution correspond to
a more collapsed and a more accessible DNA-binding
cleft than seen in any of the available yeast crystallo-
graphic models (see Discussion).
Other high-variance areas of the structure were harder
to interpret, as changes were more subtle and thus dif-
ficult to visualize at this resolution. Significantly more
Architecture and Flexibility of Human RNAP II
1697data would be required to accurately separate all the po-
tential conformations and to achieve higher-resolution
reconstructions that would allow us to use flexible-
docking procedures with the yeast crystallographic
models.
In conclusion, our analysis establishes that conforma-
tional variability exists in hRNAPII in solution and in the
absence of nucleic acids. We localized the variable
areas in the structure by 3D variance and identified the
corresponding regions of the yeast crystal structure.
Our analysis confirms some mechanistic similarities ex-
pected between the human and the yeast RNAPII en-
zymes but also indicates that the human complex is
more flexible or, alternatively, that the crystal structures
of the yeast enzyme have not yet sampled a similarly ex-
tensive conformational landscape.
Discussion
Human RNAPII Architecture in Solution versus
the Yeast Crystal Structures
Over the past 5 years, a wealth of structural data has be-
come available for RNA polymerase enzymes (Asturias
et al., 1998; Jeruzalmi and Steitz, 1998; Cheetham
et al., 1999; Zhang et al., 1999; Cramer et al., 2001; Gnatt
et al., 2001; Murakami et al., 2002; Tahirov et al., 2002;
Asturias, 2004). The structural characterization of the
human RNAPII lags behind, hampered, among other
factors, by the inability to obtain large quantities of the
purified complex. Here, to the best of our knowledge,
we present the first 3D structure of the human RNAPII
complex, as obtained by cryo-EM and single-particle re-
construction, a methodology that is less demanding on
sample amounts. Our study defines the overall architec-
ture of hRNAPII and its similarities and differences with
the yeast complex at a resolution of 22 A˚. It shows that
the overall features are highly conserved between the
yeast and human complexes but that some significant
differences are apparent. Some of these differences be-
tween hRNAPII and the crystal yRNAPII structures can
be explained by differences in size of some of the pro-
teins making the complex, such as the smaller stalk. It
is also likely that the disordered regions in the crystal
structure are contributing to our reconstruction because
of its lower resolution. The most significant example is
a large segment of yRbp6 that was not visualized in
the crystal structure. In hRNAPII, the segment is shorter,
but still 40 amino acids in this region could be contribut-
ing significantly to the enlarged jaw region on the Rbp5
side of the hRNAPII reconstruction (Figure 4B5). We pro-
pose that some of the additional density seen between
the wall and clamp in hRNAPII could be due to the
CTD of Rpb1. The CTD has been shown by NMR studies
to be highly disordered (Cagas and Corden, 1995), in
agreement with the inability to account for its mass in
the electron density of the yeast crystal structures. Inter-
estingly, electron crystallographic studies of 2D crystals
of yRNAPII indicated that the CTD trailed behind the
complex as a large globular mass (Meredith et al.,
1996), but this mass has not been detected in single-
particle EM studies of yRNAPII (Craighead et al., 2002).
In our reconstruction, small protuberances emanating
from behind the stalk, at our proposed site for the
CTD, can be seen at lower density threshold (notshown), as well as some minor mass filling up part of
the RNA exit channel between the wall and the clamp
(see Figure 2B, left), suggesting the presence of disor-
dered mass in these regions. Additionally, some 3D var-
iance is visible as a trail of satellites between the posi-
tion of the linker and the RNA exit groove (Figure 4B6).
Future studies of hRNAPII treated with a protease to re-
move the CTD could shed light on this assignment.
Coexistence of Distinct Conformations of hRNAPII
in Solution
Our study using 3D variance analysis has allowed us to
define the regions of major conformational flexibility in
hRNAPII and to demonstrate that several conformations
of hRNAPII coexist in solution. Both the localization of
the 3D variance and the two conformations that we
were able to isolate by partitioning our EM data suggest
that hRNAPII is composed of several modules, much as
proposed for the yeast polymerase (Cramer et al., 2001;
Craighead et al., 2002). These modules are able to move
relative to each other, giving rise to the different ob-
served conformations. We identified the clamp (Rpb1
and Rpb2), the jaw lobe (Rpb2, Rbp1, and Rpb9), and
the Rpb5 jaw as large mobile elements and the stalk
as a variable element linked to those movements. Not
surprisingly, one major region highlighted by the 3D var-
iance was the clamp. Indeed, the clamp movement is the
most striking conformational change identified in the
crystallographic studies of the yeast RNAPII (Cramer
et al., 2000; Gnatt et al., 2001). Visualizing the large con-
formational change that results in clamping of the DNA
in its active site was an important step in understanding
the processivity of RNAPII. Our study indicates that the
clamp region of the human enzyme is mobile and there-
fore that the innate flexibility of the complex is present in
the absence of DNA. The conformational landscape
present in hRNAPII in solution, in the absence of nucleic
acid or additional factors, is likely to reflect the variety of
functional states sampled by the complex during its in-
teraction with different ligands and thus to be of rele-
vance in our understanding of RNAPII function. In spite
of the general similarities, there are differences between
the yeast crystal structures and human complex pre-
sented here, as neither of our two conformers exactly
corresponds to any known yeast crystallographic
models.
Mobile Elements in Human versus Yeast RNAPII
and Functional Implications
The closed conformation 1 of hRNAP II resembles most
closely the yeast core complex (lacking Rpb4/7) bound
to TFIIB. In this yeast crystal structure, the jaw lobe
has rotated up, closing the cleft, while TFIIB contacts
yRNAPII at the ‘‘dock’’ domain and extends a ‘‘finger’’
domain into the active site of the enzyme, where it oc-
cupies the DNA/RNA hybrid site of the transcribing com-
plex (Bushnell et al., 2004). We observe a similar type of
rotation of the jaw-Rpb2 lobe module in conformation 1
of hRNAPII, indicated by the arrow in Figure 5A (bottom).
However, in this conformation the cleft is more col-
lapsed than in the TFIIB/yRNAPII complex, due to an
ampler rotation of the jaw lobe and a slight simultaneous
downward swinging motion of the clamp. As a result, it
Structure
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date the DNA/RNA hybrid in an elongation complex.
In clear contrast, conformation 2 displays a widely
open cleft, especially toward the downstream DNA. In
the yeast crystal structures, the presence of the Rpb4/
7 stalk complex constrains the clamp in a closed confor-
mation, similar to the elongation complex, even in the
absence of nucleic acids (Gnatt et al., 2001; Ketten-
berger et al., 2004), thus precluding DNA from entering
or exiting the cleft. Our study indicates that the full hu-
man RNAPII complex, as observed in solution, exhibits
a significantly larger range of motions than the full yeast
counterpart.
Two main types of clamp motion have been described
for the yeast core enzyme when the stalk complex is ab-
sent. First, the clamp can swing in (when seen in the ori-
entation of Figure 2, right) to partially close the cleft, as is
observed when comparing the free and the DNA/RNA-
hybrid-bound core enzyme (Gnatt et al., 2001). Second,
the clamp can rotate around the axis of viewing in the
same orientation. The ‘‘swinging out’’ motion is pre-
cluded in the yeast RNAPII by the presence of Rpb4/
Rpb7 forming a wedge into the core complex (Armache
et al., 2003; Bushnell and Kornberg, 2003). On the other
hand, some level of rotation should still be possible in
the full complex. Conformation 2 of the human complex
shows such a rotation of the clamp (arrow in Figure 5B,
bottom) and thus the wider opening of the cleft toward
the downstream DNA. Furthermore, a small degree of
clamp swinging cannot be totally ruled out. We propose
that a likely explanation for this enhanced flexibility of
the clamp in the human complex may be related to the
differences between the human and yeast stalks. There
are significant differences between the two species in
sequence, and likely in fold (Meka et al., 2005), at the N
terminus of Rpb4 that contacts the core complex at
the clamp core. Such differences at this key location
are likely to have an effect in the coupling between the
stalk and the clamp, of relevance for the process of tran-
scription initiation. The differences in protein sequence
and size of the human and yeast stalks result in a change
in position of the stalk with respect to the core complex
(seen in our EM structures and in our homology model)
and most likely in its freedom of movement. In turn,
the geometry of the stalk attachment and its dynamics
are most likely to have consequences in the flexibility
of the human clamp, allowing movements that appear
more implausible in the yeast structure. The yeast
Rpb4/7 stalk is known to play an essential role at the ini-
tiation stage of transcription (Edwards et al., 1991) and
has been proposed to act by restricting the clamp posi-
tion and imposing a initiation-ready state in two switch
regions (Armache et al., 2003). Interestingly, it is likely
that the stalk orientation seen in the yeast crystal struc-
tures is imposed by crystal packing (Armache et al.,
2003). In contrast, the hRNAPII complex in our studies
is in solution, and therefore the unconstrained stalk
may allow more flexibility of the clamp position. Thus,
the differences in the amplitude and direction of move-
ment of the clamp described in this study with respect
to the crystallographic structures of the yeast enzyme
may be due to a combination of the intrinsic differences
between the clamp/stalk connection in the yeast and hu-
man complexes (Meka et al., 2005) and to the crystallo-graphic versus solution states of the two types of stud-
ies. More EM data will allow in the future both finer
conformational separation and higher resolution in order
to describe the complex flexibility of hRNAPII more ac-
curately.
Even though the yeast RNAPII shares high sequence
and structural similarity with the human enzyme, there
are likely to be significant functional differences in
RNAPII complexes associated with the increased
complexity of higher eukaryotic systems. This is true
not only of transcription but especially of TCR, defects
in which result in very early death from Cockayne
syndrome in humans but produce little phenotype in
yeast. In addition to the jaw-lobe module rotation be-
tween the two conformations, our 3D variance analysis
showed additional mobility of the jaw region of hRNAPII
(Figure 4B4). The crystallographic studies of the elon-
gating yRNAPII show that the downstream DNA passes
by this mobile element (Gnatt et al., 2001; Kettenberger
et al., 2004). Thus, the mobility that we observe suggests
that in the context of TCR the flexibility of the jaws would
allow to ‘‘ride over’’ the lesion without persistent distor-
tions. Our understanding of the complex, multicompo-
nent processes of transcription and TCR in humans
requires the study of proteins specific to the human sys-
tem. The human RNAPII structure presented here serves
as a platform to build up higher-order transcription and
TCR complexes and thus gain information that may be
unique to the human RNAPII system.
Experimental Procedures
hRNAPII Purification and Activity
Human RNAPII was inmunopurified from HeLa cell nuclei with a CTD
antibody as previously described (Thompson et al., 1990; Maldo-
nado et al., 1996) (see Supplemental Experimental Procedures). Af-
ter the affinity purification, the protein was further purified by ion-ex-
change chromatography to separate the different phosphorylation
states of the protein complex. Unphosphorylated protein was
used for all our experiments. Fractions were immediately dispensed
into 5 ml aliquots and frozen in liquid nitrogen for later use. Transcrip-
tional activity was measured by using a promoter-less RNA-poly-
merase-initiation system prepared as described by Kashlev and co-
workers (Kireeva et al., 2000).
EM Sample Preparation and Data Collection
Cryo-negative stain grids were prepared as previously described
(Adrian et al., 1998) (see Supplemental Experimental Procedures).
EM data was collected on an FEI CM200-FEG electron microscope,
with a calibrated magnification of 350280 while keeping the speci-
men temperature at approximately 2180C. Images were taken un-
der low-dose conditions (17 e2/A˚2) with a defocus range of 1.2 to 3.6
mm and recorded on Kodak SO163 plate films. The quality of the mi-
crographs was checked by visual inspection for astigmatism and
drift. The best 19 micrographs were digitized on a Nikon Super Cool-
scan 8000 with a 6.353 mm raster size, resulting in a pixel size of
1.25 A˚. Transmission values from the scanner were converted to
optical density with tm2od, an in-house convenience script that em-
ploys the proc2d module of EMAN (see http://cryoem.berkeley.edu/
wslaton/bash/tm2od.shtml). Particles were then decimated to
2.5 A˚/pixel.
Image Processing
The EMAN software package (Ludtke et al., 1999) was used to man-
ually establish particle coordinates (boxer) and window 9225 images
at a size of 1203 120 pixels (batchboxer). Two methodologies were
employed to estimate the contrast transfer function (CTF) for each
particle. The first method used the ctfit module of EMAN (Ludtke
et al., 1999) to estimate the defocus for an entire micrograph with
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particles by using IMAGIC (van Heel et al., 1996). This procedure cor-
rected the individual image CTFs by flipping the phase only, without
regard for the amplitudes. The second method relied on the ctftilt
program of FREALIGN to estimate defocus and astigmatism for
each particle (Mindell and Grigorieff, 2003). The program determines
the specimen tilt parameters by measuring the defocus at a series of
locations on the image while constraining them to a single plane.
This information was stored and used for refinement in FREALIGN.
Particles were subjected to multivariate statistical analysis (MSA)
and hierarchical ascendant classification (HAC). Initial Euler angle
assignment was performed with SPIDER (Frank et al., 1996) by using
a projection matching strategy. The yRNAPII crystal structure (ini-
tially PDB entry 1NT9) was low-pass Fermi filtered to a spatial fre-
quency of 1/50 A˚21 to serve as initial reference, thus allowing align-
ment of the overall shape without bias from high-resolution
frequencies. Final refinement and full CTF correction of the SPIDER
model were performed with the image-processing software pack-
age FREALIGN (Grigorieff, 1998) (see Supplemental Experimental
Procedures). The resolution of the final reconstruction was esti-
mated according to the 0.143 cut off in the Fourier shell correlation
curve (Rosenthal and Henderson, 2003; Stewart and Grigorieff,
2004) (Figure S2).
To assess the potential conformational heterogeneity, 2D analysis
was again performed with IMAGIC on particles from angular distri-
bution groups generated during projection matching. Additionally,
3D variance was calculated as previously described (Grob et al.,
2006; Penczek et al., 2006a) (see Supplemental Experimental
Procedures).
Targeted Classification and Reconstruction
The different regions of the 3D variance were selected with spherical
masks centered at the highest-variance peaks in SPIDER. They were
then individually projected in quasi-evenly distributed directions
(15 spacing), identical to the directions of the particle ‘‘angular
groups,’’ to generate a series of 2D masks. Two-dimensional classi-
fication of the particle data belonging to each angular group was
performed within the corresponding masks as in Grob et al. (2006)
and Penczek et al. (2006b). Classification for the high-variance re-
gion between the clamp and the lobe (region 1, Figure 4) gave the
clearest result, with two main classes corresponding to a higher or
lower density within the mask. The data were partitioned accord-
ingly for each view into two groups, ‘‘closed’’ or ‘‘open’’ clamp.
Two 3D reconstructions were obtained from the particle groups,
which were then refined simultaneously against the entire data set;
the final particle assignment to either conformation was determined
by the highest crosscorrelation coefficient. An additional refinement
of the alignment parameters was performed for each separate group
in FREALIGN (Grigorieff, 1998). The 3D variance was calculated
again for each group of particles, showing a notably reduced vari-
ance level after partition of the data.
Docking of the Crystallographic Data and Volume Rendering
The atomic coordinates of the 12 subunit yeast RNAPII (PDB 1Y1V)
(Kettenberger et al., 2004) were initially docked manually into the EM
density map of the human polymerase in Chimera. The initial fit was
refined with the rigid-body docking program colores from the SITUS
package (Wriggers and Birmanns, 2001; Chacon and Wriggers,
2002) (see Supplemental Experimental Procedures).
All the volumes represented were filtered to 22 A˚ resolution, as de-
termined by the FSC criterion at 0.143, with a cosine type filter. The
density threshold was calculated to include a protein volume corre-
sponding to 517 kDa, the molecular mass of holo-hRNAPII. The 3D
density maps and atomic structures were rendered with the UCSF
Chimera package from the Computer Graphics Laboratory, Univer-
sity of California, San Francisco (Pettersen et al., 2004) (supported
by NIH P41 RR-01081).
For comparing the human and the yeast enzymes, we visualized
sequence alignments obtained in clustalW (Thompson et al., 1994)
with the Chimera package tool Multalign Viewer to visualize inser-
tions and deletions on the docked yeast crystal structure (PDB
1Y1V). Parts that were absent from the yeast model (inserts in
hRNAPII or nonlocalized loops and termini) were drawn where they
should be inserted according to the sequence (structure unknown).Supplemental Data
Supplemental Data include purification and activity procedures for
human RNAPII, details on EM data collection and image processing,
analysis of insertions and deletions in yeast versus human RNAP II
subunits, and building of a homology model for human RNAPII
based on the yeast crystal structure. This information is available
at http://www.structure.org/cgi/content/full/14/11/1691/DC1/.
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